Overview
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus associated with a wide spectrum of clinical manifestations, ranging from asymptomatic infection to severe and chronic diseases. Chronic active Epstein-Barr virus disease (CAEBV) represents a particularly challenging subset characterized by persistent viral activity and diverse clinical presentations. This condition predominantly affects Asian and Native American populations, with notable differences in prognosis between pediatric and adult patients. CAEBV can manifest in various ways, including prolonged fever, mucosal lesions, and systemic complications, often complicating diagnosis and management. Understanding the epidemiology, clinical presentation, diagnostic challenges, and management strategies is crucial for effective patient care, especially in vulnerable populations such as immunocompromised individuals.
Epidemiology
Chronic active Epstein-Barr virus disease (CAEBV) predominantly affects Asian and Native American ethnic groups, highlighting geographic and demographic predispositions [PMID:41112306]. Studies have shown that the incidence and severity of CAEBV tend to be higher in these populations, possibly due to genetic or environmental factors that influence viral persistence and immune response. Notably, adults diagnosed with CAEBV often experience a worse prognosis compared to pediatric patients, suggesting that age-related immune differences play a significant role in disease outcomes [PMID:41112306]. This disparity underscores the need for tailored clinical approaches based on patient age and underlying health status. Additionally, immunocompromised individuals are at increased risk for severe EBV-related complications, emphasizing the importance of vigilant monitoring and early intervention in these groups.
Clinical Presentation
The clinical presentation of CAEBV is highly variable, encompassing both systemic and localized symptoms that can mimic other chronic conditions, complicating early diagnosis. An illustrative case involves an 18-year-old male who experienced intermittent fever, nasal congestion, and persistent bloody nasal discharge over four years, initially misdiagnosed as chronic sinusitis [PMID:41112306]. Such prolonged and refractory symptoms are characteristic of CAEBV and highlight the necessity for considering this diagnosis in patients with unexplained chronic illness. Another notable presentation is seen in a 10-year-old immunosuppressed girl who developed painful intraoral lesions—white to flesh-colored, soft papules and plaques—diagnosed as Heck's disease, a rare EBV-associated condition [PMID:33275301]. These lesions, often overlooked, can be indicative of underlying EBV activity, particularly in immunocompromised hosts. The diversity of symptoms—from systemic fevers to localized mucosal lesions—emphasizes the importance of a comprehensive clinical evaluation in suspected cases.
Diagnosis
Diagnosing CAEBV poses significant challenges due to its varied clinical presentations and the need for extensive diagnostic workup. The cases described required multiple pathological examinations across different healthcare facilities, underscoring the complexity and multidisciplinary approach often required [PMID:41112306]. Laboratory investigations typically include serological tests to detect EBV-specific antibodies, though these can be non-specific in chronic cases. Histopathological examination of affected tissues, such as those from mucosal lesions or lymph nodes, can reveal characteristic changes indicative of active EBV infection. In the case of Heck's disease, molecular diagnostics played a crucial role; PCR detection of HPV type 13 in biopsied buccal tissue confirmed the diagnosis, although it's important to note that Heck's disease is primarily associated with EBV rather than HPV [PMID:33275301]. This highlights the necessity of precise molecular testing to differentiate between EBV-related conditions and other viral or non-viral etiologies. Imaging studies, such as MRI or CT scans, may also be employed to assess organ involvement and monitor disease progression.
Differential Diagnosis
The differential diagnosis for CAEBV is broad, encompassing a range of chronic inflammatory and infectious conditions that can present with similar symptoms. Early symptoms such as prolonged fever and chronic sinusitis can mimic conditions like chronic sinusitis, autoimmune disorders, or other persistent viral infections [PMID:41112306]. Mucosal lesions, particularly those in the oral cavity, can be confused with other viral exanthems, fungal infections, or even malignancies. In clinical practice, distinguishing CAEBV from these conditions requires a thorough history, physical examination, and targeted diagnostic testing. Key considerations include the duration of symptoms, immune status of the patient, and the presence of systemic manifestations. Early recognition and accurate differentiation are critical to initiating appropriate management and preventing further complications.
Management
The management of CAEBV is multifaceted, often requiring a combination of supportive care, immunomodulatory therapies, and sometimes surgical interventions. In the case of the 18-year-old male with chronic sinusitis-like symptoms, functional endoscopic sinus surgery and ear surgery were necessary due to persistent symptoms initially attributed to sinusitis and otitis media [PMID:41112306]. These interventions highlight the complexity in managing CAEBV, where addressing secondary complications is often part of the treatment plan. For immunosuppressed patients, such as the 10-year-old girl with EBV-associated smooth muscle tumors and Heck's disease, immune reconstitution strategies and close monitoring for opportunistic infections are paramount [PMID:33275301]. Immunomodulatory agents, including corticosteroids and antiviral therapies targeting EBV, may be considered based on the severity and specific manifestations of the disease. Supportive care, including pain management and nutritional support, is essential to improve quality of life and manage symptoms effectively. Regular follow-up and multidisciplinary collaboration among immunologists, hematologists, and surgeons are crucial for comprehensive patient care.
Special Populations
Immunocompromised individuals, particularly children, face heightened risks when affected by CAEBV, as evidenced by cases involving concurrent EBV-associated smooth muscle tumors and Heck's disease [PMID:33275301]. These patients often exhibit more severe clinical presentations and a broader range of complications due to their compromised immune systems. The interplay between EBV and underlying immunosuppression can lead to rare and aggressive manifestations, necessitating vigilant monitoring and tailored therapeutic approaches. Management in these populations should focus on immune support, targeted antiviral treatments, and aggressive management of complications. Close collaboration with specialists in immunology and oncology is essential to address the unique vulnerabilities and multifaceted challenges faced by immunocompromised patients with CAEBV.
Key Recommendations
References
1 Wang P, Dong D, Huang S, Wang L, Zhang H, Li Y et al.. Case Report: Two cases of chronic active Epstein-Barr virus disease presenting as refractory sinusitis. Frontiers in immunology 2025. link 2 Arbelo-Ramos N, Anderson K, Joshi A, Wieland C, Tyring S, Rady P et al.. Heck's disease occurring after Epstein-Barr virus-associated smooth muscle tumors in an immunosuppressed child. Pediatric dermatology 2021. link
2 papers cited of 3 indexed.